Chen Feng
Feng Chen, Section of Radiology, Department of Medical Diagnostic Sciences, Faculty of Medicine, University of Leuven, 3000 Leuven, Belgium.
World J Radiol. 2011 Apr 28;3(4):120-4. doi: 10.4329/wjr.v3.i4.120.
Dr. Feng Chen is a chief medical doctor and the vice chairman of the Department of Radiology in Zhong Da Hospital at Southeast University, Nanjing, China and a senior researcher in the Department of Radiology at the Catholic University of Leuven, Belgium. His main areas of interest are translational imaging research including stroke, tumor angiogenesis, assessment of therapeutic response in solid tumors, and magnetic resonance contrast media. Dr. Feng Chen has published 44 scientific papers in peer-reviewed international journals. He and his colleagues have developed an imaging platform which includes animal models, animal preparations and multiparametric magnetic resonance imaging (MRI) protocols for translational animal imaging research using clinical machines. His MRI findings on rodent stroke are considered to "serve as a model for future laboratory investigations of treatment of acute stroke and unify the approaches developed for clinical studies". He and his colleagues have introduced a novel liver tumor model in rodents, in which a series of studies concerning the antitumor activity of vascular disrupting agents have been successively conducted and assessed by in vivo MRI, especially by diffusion weighted imaging as an imaging biomarker. His goal is to provide valuable references for clinical practice and to contribute to the translation of animal imaging research into patient applications.
陈峰博士是中国南京东南大学附属中大医院放射科主任医师及副主任，也是比利时鲁汶天主教大学放射科高级研究员。他主要的研究领域是转化成像研究，包括中风、肿瘤血管生成、实体瘤治疗反应评估以及磁共振造影剂。陈峰博士已在同行评审的国际期刊上发表了44篇科学论文。他和同事们开发了一个成像平台，该平台包括动物模型、动物准备以及使用临床设备进行转化动物成像研究的多参数磁共振成像（MRI）方案。他在啮齿动物中风方面的MRI研究结果被认为“可作为未来急性中风治疗实验室研究的模型，并统一为临床研究开发的方法”。他和同事们在啮齿动物中引入了一种新型肝肿瘤模型，在该模型中，已相继开展了一系列关于血管破坏剂抗肿瘤活性的研究，并通过体内MRI进行评估，尤其是将扩散加权成像作为成像生物标志物。他的目标是为临床实践提供有价值的参考，并为将动物成像研究转化为患者应用做出贡献。
